• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细节决定成败:静脉输液给药闭环文档系统如何促进和影响患者安全。

The devil is in the detail: How a closed-loop documentation system for IV infusion administration contributes to and compromises patient safety.

机构信息

University College London, UK.

University College London, UK; Imperial College Healthcare NHS Trust, UK.

出版信息

Health Informatics J. 2020 Mar;26(1):576-591. doi: 10.1177/1460458219839574. Epub 2019 Apr 15.

DOI:10.1177/1460458219839574
PMID:30983475
Abstract

Many studies have highlighted the patient safety risks in intravenous medication administration, and various technological solutions have been proposed to mitigate those risks, including 'smart pumps' and closed-loop systems. Few studies describe these implementations in detail. In this article, we report on a sociotechnical investigation of a closed-loop documentation system linked with smart pumps for intravenous infusion administration on an intensive care unit. The smart pumps are 'mapped' to an electronic prescribing and medication administration system, allowing infusion rates, volumes and boluses of intravenous medication to be monitored in real time. Ethnographic observations were conducted over 37 h, including direct observation of infusion administration (n = 23 infusions), discussions with clinical staff and semi-structured interviews with intensive care unit managers (n = 2). Analysis was based on the Distributed Cognition for Teamwork (DiCoT) method to understand how information is processed across individuals, teams and technologies. We report on how the system works in context, and identify contributions and compromises to patient safety with new risks that need to be managed at bedside and intensive care unit level.

摘要

许多研究都强调了静脉给药中的患者安全风险,并且已经提出了各种技术解决方案来降低这些风险,包括“智能输液泵”和闭环系统。很少有研究详细描述这些实施情况。在本文中,我们报告了一项针对与智能输液泵相关联的闭环文档系统的社会技术调查,该系统用于重症监护病房的静脉输液管理。智能输液泵与电子医嘱和药物管理系统进行“映射”,允许实时监测输液速度、容量和静脉药物推注量。进行了 37 小时的人种学观察,包括直接观察输液管理(n=23 次输液)、与临床工作人员的讨论以及对重症监护病房管理人员的半结构化访谈(n=2)。分析基于团队分布式认知(DiCoT)方法,以了解信息如何在个人、团队和技术之间进行处理。我们报告了系统在上下文中的工作方式,并确定了与新风险相关的对患者安全的贡献和折衷,这些风险需要在床边和重症监护病房层面进行管理。

相似文献

1
The devil is in the detail: How a closed-loop documentation system for IV infusion administration contributes to and compromises patient safety.细节决定成败:静脉输液给药闭环文档系统如何促进和影响患者安全。
Health Informatics J. 2020 Mar;26(1):576-591. doi: 10.1177/1460458219839574. Epub 2019 Apr 15.
2
Intravenous Smart Pumps: Usability Issues, Intravenous Medication Administration Error, and Patient Safety.静脉智能输液泵:可用性问题、静脉用药错误与患者安全
Crit Care Nurs Clin North Am. 2018 Jun;30(2):215-224. doi: 10.1016/j.cnc.2018.02.004. Epub 2018 Apr 7.
3
Implementing smart infusion pumps with dose-error reduction software: real-world experiences.实施配备剂量误差减少软件的智能输液泵:实际应用经验。
Br J Nurs. 2017 Apr 27;26(8):S13-S16. doi: 10.12968/bjon.2017.26.8.S13.
4
Analysis of event logs from syringe pumps: a retrospective pilot study to assess possible effects of syringe pumps on safety in a university hospital critical care unit in Germany.从注射器泵中分析事件日志:一项回顾性试点研究,以评估德国一所大学附属医院重症监护病房中注射器泵对安全性的可能影响。
Drug Saf. 2012 Jul 1;35(7):563-74. doi: 10.2165/11597350-000000000-00000.
5
Exploring the Current Landscape of Intravenous Infusion Practices and Errors (ECLIPSE): protocol for a mixed-methods observational study.探索静脉输液实践与差错的现状(ECLIPSE):一项混合方法观察性研究的方案
BMJ Open. 2016 Mar 3;6(3):e009777. doi: 10.1136/bmjopen-2015-009777.
6
A controlled trial of smart infusion pumps to improve medication safety in critically ill patients.一项关于智能输液泵改善重症患者用药安全的对照试验。
Crit Care Med. 2005 Mar;33(3):533-40. doi: 10.1097/01.ccm.0000155912.73313.cd.
7
Discrepancies between medication orders and infusion pump programming in a paediatric intensive care unit.儿科重症监护病房中药物医嘱与输液泵程序设置之间的差异。
Qual Saf Health Care. 2010 Oct;19 Suppl 3:i31-5. doi: 10.1136/qshc.2009.036384.
8
Advancing medication infusion safety through the clinical integration of technology.通过技术的临床整合提高药物输注安全性。
Hosp Pract (1995). 2013 Oct-Nov;41(4):7-14. doi: 10.3810/hp.2013.10.1075.
9
Intravenous Medication Administration Safety with Smart Infusion Pumps in the Neonatal Intensive Care Unit: An Observational Study.静脉药物输注安全与新生儿重症监护病房中的智能输液泵:一项观察性研究。
Drug Saf. 2024 Jan;47(1):29-38. doi: 10.1007/s40264-023-01365-6. Epub 2023 Oct 27.
10
The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study.与智能输液泵相关的静脉用药给药错误发生率:一项多医院观察性研究。
BMJ Qual Saf. 2017 Feb;26(2):131-140. doi: 10.1136/bmjqs-2015-004465. Epub 2016 Feb 23.

引用本文的文献

1
Dose error reduction software in medication safety risk management - optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation.剂量错误减少软件在药物安全风险管理中的应用-在实施前优化新生儿重症监护病房智能输液泵的给药限制。
BMC Pediatr. 2022 Mar 8;22(1):118. doi: 10.1186/s12887-022-03183-8.
2
Smart agent system for insulin infusion protocol management: a simulation-based human factors evaluation study.智能代理系统在胰岛素输注方案管理中的应用:基于模拟的人为因素评估研究。
BMJ Qual Saf. 2021 Nov;30(11):893-900. doi: 10.1136/bmjqs-2020-011420. Epub 2021 Mar 10.
3
Implementation of Smart Infusion Pumps: A Scoping Review and Case Study Discussion of the Evidence of the Role of the Pharmacist.
智能输液泵的应用:关于药师作用证据的范围综述与案例研究讨论
Pharmacy (Basel). 2020 Dec 16;8(4):239. doi: 10.3390/pharmacy8040239.
4
Direct Observational Study of Interfaced Smart-Pumps in Pediatric Intensive Care.接口智能输液泵在儿科重症监护中的直接观察研究。
Appl Clin Inform. 2020 Aug;11(4):659-670. doi: 10.1055/s-0040-1716527. Epub 2020 Oct 7.
5
Changes in medication administration error rates associated with the introduction of electronic medication systems in hospitals: a multisite controlled before and after study.医疗机构引入电子医嘱系统后与给药错误率变化相关的多站点对照前后研究。
BMJ Health Care Inform. 2020 Aug;27(3). doi: 10.1136/bmjhci-2020-100170.